AAPS has announced the five graduate students awarded with a $10,000 fellowship for their research efforts in global health solutions.
On Sep. 7, 2017, the American Association of Pharmaceutical Scientists (AAPS) Foundation awarded five graduate students each with a $10,000 fellowship. According to AAPS, the students’ fields of discipline include liver fibrosis, breast cancer, and sepsis. The 2017 graduate student fellowship winners are:
Elizabeth Gibson
Vanderbilt University
Novel Naphthyridone/Aminopipiridine-Derived Type I Topoisomerase-Targeted Antibacterials
Akshay Jain
University of Missouri Kansas City
Development of Protein and Peptide Based Delivery System for Targeted Therapy of Liver Fibrosis
Dandan Luo
University of Buffalo
Doxorubicin Encapsulated in Porphyrin-Phospholipid (PoP) Liposomes for Chemophototherapy of Solid Tumors
John Schardt
University of Maryland
Engineered Multivalency for Improved HER3 Downregulation and Cancer Therapy
Yangjie Wei
University of Kansas
Lumazine Synthase as a Nanoplatform for the Development of Ricin-Anthrax Combination Vaccine
Additionally, AAPS will continue to fund the following 2016 fellowships:
Mohd M. Khan
University of Maryland School of Pharmacy, Baltimore
Anti-Sepsis Therapeutics Design using Structure/Function Relationship
Brandon Lucke-Wold
West Virginia University
The Pathologic Mechanisms Associated with Chronic Traumatic Encephalopathy
The AAPS Foundation was formed in Nov. 2013 and provides graduate students and assistant faculty members with the resources needed to continue their research and education. AAPS Foundation K–12 programs also teach students about career opportunities available in the pharmaceutical sciences.
Source: AAPS
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.